Hostname: page-component-586b7cd67f-dlnhk Total loading time: 0 Render date: 2024-11-30T01:00:19.065Z Has data issue: false hasContentIssue false

The EMEA ADHES survey in schizophrenia, an initiative to raise awareness of non-adherence to medication. demographics and methodology

Published online by Cambridge University Press:  16 April 2020

J.M. Olivares
Affiliation:
Department of Psychiatry, Hospital Meixoeiro, Complejo Hospitalario Universitario de Vigo, Vigo, Spain
K. Alptekin
Affiliation:
Department of Psychiatry, Dokuz Eylül University School of Medicine, Izmir, Turkey
J.M. Azorin
Affiliation:
Department of Psychiatry, Sainte Marguerite Hospital, Marseille, France
F. Cañas
Affiliation:
Department of Psychiatry, Hospital Dr. R. Lafora, Madrid, Spain
V. Dubois
Affiliation:
Cliniques Unversitaires St-Luc, Bruxelles, Belgium
R. Emsley
Affiliation:
Department of Psychiatry, Faculty of Health Sciences, University of Stellenbosch, Cape Twon, South Africa
P. Gorwood
Affiliation:
CMME, Hopital Sainte-Anne (Paris Descartes), Paris, France
P. Haddad
Affiliation:
Salford and Trafford Mental Health NHS Trust and Department of Psychiatry, University of Manchester, Manchester, UK
D. Naber
Affiliation:
Universitätsklinikum Hamburg-Eppendorf, Klinik für Psychiatrie und Psychotherapie, Hamburg, Germany
G. Papageorgiou
Affiliation:
Department of Psychiatry, Evangelismos General Hospital, Athens, Greece
M. Roca
Affiliation:
Unidad de Psiquiatría, Hospital Juan March, Institut Universitari d’Investigació en Ciències de la Salut (IUNICS) Universitat de les Illes Balears, Palma de Mallorca, Spain
P. Thomas
Affiliation:
Department of Psychiatry, Fontan Hospital CHRU Lille, University of Lille, Lille, France
L. Martinez
Affiliation:
Medical Affairs, Janssen, Madrid, Spain
A. Schreiner
Affiliation:
Medical Affairs, Janssen, Neuss, Germany

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Rates of non-adherence of up to 72% have being reported, in schizophrenia, depending on the method used and the patient population. Rates of approximately 59% over 1 year have been reported for individuals with a first episode. Patients who stop medication are almost five times more likely to experience relapse than adherent patients. Failure to adhere to medication can have a major impact on the course of illness and treatment outcomes.

Objectives

The EMEA (Europe, Middle East and Africa) ADHES schizophrenia survey was a survey of psychiatrists across the region, treating patients with schizophrenia, designed to canvas their perceptions of assessment, potential reasons and management for partial or non-adherence to medication amongst their patients.

Aims

To present methodology and demographics of the EMEA ADHES survey in schizophrenia.

Methods

The EMEA ADHES survey comprised 20 questions and was conducted in 36 countries across EMEA. In addition to recording the gender, age and practice setting of the respondents, questions related directly to the issue of partial-/non-adherence in patients with schizophrenia.

Results

The survey was conducted amongst psychiatrists (including neurologists with psychiatric background in Germany) from January - March 2010. Results were obtained from 4722 respondents. Psychiatrists perceived that during the previous month more than half of their patients (53%) were partially or non-adherent across all EMEA regions

Discussion

The EMEA ADHES schizophrenia survey is a large and geographically broad survey providing insight on psychiatrists’ perceptions of the assessment, causes and management of partial and non-adherence to medication.

Type
P03-276
Copyright
Copyright © European Psychiatric Association 2011
Submit a response

Comments

No Comments have been published for this article.